Institution Directory

Clinical trials at Mount Sinai

Sites in New York, NY

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1091

Shown on this page

Current sort

Stored official records

Conditions: Anxiety, Pregnant People
Interventions: Dexmedetomidine, Remimazolam; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Malignant Solid Tumors
Interventions: TAK-505; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 15
States / cities: Orange, California • San Diego, California • San Francisco, California + 10 more

Conditions: Borderline Personality Disorder
Interventions: Cognitive Reappraisal by Distancing, Downregulate condition; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 55 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Diseases, Heart Diseases, Heart Failure
Interventions: BrioVAD System, HeartMate 3; Device
Lead sponsor: BrioHealth Solutions, Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 47
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 32 more

Conditions: Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases, HER2, HER2 + Breast Cancer, HER2 + Gastric Cancer, HER2 Mutation-Related Tumors, HER2-Positive Solid Tumors, HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Colorectal Cancer, HER2-positive Gastroesophageal Cancer, NSCLC (Non-small Cell Lung Cancer)
Interventions: IAM1363; Drug
Lead sponsor: Iambic Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 383 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 29
States / cities: La Jolla, California • Los Angeles, California • Aurora, Colorado + 23 more

Conditions: Acute Myocardial Infarction (AMI), Cardiovascular Risk
Interventions: Placebo, Ziltivekimab; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 188
States / cities: Alexander City, Alabama • Birmingham, Alabama • Fairhope, Alabama + 156 more

Conditions: Adenocarcinoma, Pancreatic Ductal
Interventions: Atezolizumab, Autogene cevumeran, mFOLFIRINOX; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 30
States / cities: Los Angeles, California • Newport Beach, California • San Francisco, California + 22 more

Conditions: AAA, AAA - Abdominal Aortic Aneurysm
Interventions: Alto Abdominal Stent Graft System, FDA Approved EVAR AAA Graft Systems; Device
Lead sponsor: Endologix; Industry
Eligibility: 21 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2032
U.S. locations: 29
States / cities: Huntsville, Alabama • Tucson, Arizona • Fayetteville, Arkansas + 25 more

Conditions: EPP, XLP
Interventions: MT-7117; Drug
Lead sponsor: Tanabe Pharma America, Inc.; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 13
States / cities: Huntington Beach, California • San Francisco, California • Miami, Florida + 10 more

Conditions: Pregnancy, Type 1 Diabetes
Interventions: Automated Insulin Delivery (AID); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 4
States / cities: Stanford, California • Aurora, Colorado • Rochester, Minnesota + 1 more

Conditions: Cervical Dystonia
Interventions: Corabotase, Placebo; Biological · Other
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 10
States / cities: Tucson, Arizona • Fountain Valley, California • Loma Linda, California + 7 more

Conditions: Coronary Artery Disease
Interventions: Coronary artery bypass grafting, Percutaneous coronary intervention; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2039
U.S. locations: 18
States / cities: Glendale, California • Atlanta, Georgia • Carmel, Indiana + 12 more

About this Mount Sinai institution page

What this page lists: ClinicalTrials.gov records that list Mount Sinai in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Mount Sinai

Filter and sort this campus

Stored official records

Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

A Study of TAK-505 in Adults With Solid Tumors

Cognitive Reappraisal Training for Borderline Personality (BPD)

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

A Phase 1/1b Study of IAM1363 in HER2 Cancers

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

About this Mount Sinai institution page